학술논문
Translational Focus on Targeting HDAC6 with Ricolinostat Confirms Potent Activity in Preclinical Models of Lymphoma and a Favorable Toxicity Profile in Patients with Relapsed or Refractory Lymphoma
Document Type
Abstract
Author
Source
In Blood 3 December 2015 126(23):1280-1280
Subject
Language
ISSN
0006-4971